Erika P. New

ORCID: 0000-0002-5935-5223 · 9 papers in corpus
lab-animal 2024
F&S science ·doi:10.1016/j.xfss.2023.11.003

OBJECTIVE: To study the effect of adenomyosis on the localized expression of the GATA binding proteins 2 and 6 (GATA2 and GATA6) zinc-finger transcription factors that are involved in proliferation of hematopoietic and endocrine cell lineag…

observational 2024
F&S reports ·doi:10.1016/j.xfre.2024.09.003

OBJECTIVE: To compare pregnancy outcomes after single blastocyst embryo transfer among patients whose first autologous embryo transfer was either a fresh embryo transfer or a frozen embryo transfer (FET) after a freeze-all, in the absence o…

2023
·doi:10.1016/j.fertnstert.2023.08.489
observational 2023
Systems biology in reproductive medicine ·doi:10.1080/19396368.2023.2208253

The technique and platform used for preimplantation genetic testing for aneuploidy (PGT-A) have undergone significant changes over time. The contemporary technique utilizes trophectoderm biopsy followed by next-generation sequencing (NGS). …

review 2021
·doi:10.21037/gpm-2020-mtet-03

: Gonadotropin-releasing hormone (GnRH) analogues, including both agonists and antagonists, are a second line therapy for treating endometriosis. They work by down-regulating the hypothalamic-pituitary-gonadal axis, suppressing ovulation an…

2021
·doi:10.1016/j.fertnstert.2021.07.1033
other 2020
The journal of sexual medicine ·doi:10.1016/j.jsxm.2020.05.029

BACKGROUND: As transmasculine persons utilize androgen gender affirming hormone therapy as a part of transition, guidance has been lacking on the effects of the therapy on the ovaries, especially for those who may desire retention. AIM: To…

2018
·doi:10.1016/j.fertnstert.2018.07.1143
2018
·doi:10.1016/j.jmig.2018.09.213